Immunocore Holdings plc (IMCR)
NASDAQ: IMCR · Real-Time Price · USD
36.13
-1.44 (-3.83%)
Sep 4, 2026, 4:00 PM EDT - Market closed
Immunocore Holdings Market Cap
Immunocore Holdings has a market cap or net worth of $1.86 billion as of September 4, 2026. Its market cap has increased by 4.70% in one year.
Market Cap
1.86B
Enterprise Value
1.42B
1-Year Change
4.70%
Ranking
Category
Stock Price
$36.13
ChartMarket Cap Chart
Since February 5, 2021, Immunocore Holdings's market cap has increased from $1.80B to $1.86B, an increase of 3.60%. That is a compound annual growth rate of 0.64%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 1.86B | 6.09% |
| Dec 31, 2025 | 1.75B | 18.83% |
| Dec 31, 2024 | 1.48B | -56.30% |
| Dec 29, 2023 | 3.38B | 23.54% |
| Dec 30, 2022 | 2.73B | 82.12% |
| Dec 31, 2021 | 1.50B | -16.41% |
| Feb 5, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Recursion Pharmaceuticals | 1.95B |
| GH Research | 1.94B |
| Vir Biotechnology | 1.93B |
| Stoke Therapeutics | 1.92B |
| Maravai LifeSciences Holdings | 1.90B |
| Lakefront Biotherapeutics NV | 1.86B |
| Damora Therapeutics | 1.86B |
| Syndax Pharmaceuticals | 1.84B |